Data complete?
Evaluation appropriate?
Number of risk factors for gastrointestinal perforation
Number of clinical findings that may indicate the presence of a GI perforation
Should gastrointestinal tract perforation be considered in this patient?
Caution: A qualified health practitioner should verify all results.Keep patient data confidential and comply with all legal requirements.
Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited
Purpose: To evaluate a patient being treated with bevacizumab for signs of gastrointestinal (GI) tract perforation.
Specialty: Hematology Oncology, Gastroenterology
Objective: adverse effects
ICD-10: T45.1,